THERAPEUTIC INNOVATIONS IN THE MANAGEMENT OF GLOSSALGIA DURING THE CLIMACTERIC PERIOD: A FOCUS ON QUALITY OF LIFE AND NEUROGENIC FACTORS

Glossalgia, often referred to as burning mouth syndrome (BMS), remains a challenging condition in menopausal women due to its multifactorial origin and chronic course. As traditional symptomatic approaches often fail to deliver lasting relief, recent attention has shifted to innovative therapeutic modalities that target neurogenic pathways and psychosomatic mechanisms. This review discusses current advances in the management of glossalgia in the climacteric period, emphasizing multimodal therapies aimed at improving both symptom severity and patients' quality of life. Emerging evidence supports the integration of neurotrophic agents, cognitive-behavioral therapy, and non-hormonal pharmacological options tailored to individual profiles.